CME
CME Group Inc
NASDAQ: CME · FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES
$266.08
-1.28% today
Updated 2026-06-15
Market cap
$90.52B
P/E ratio
21.38
P/S ratio
13.42x
EPS (TTM)
$11.72
Dividend yield
1.96%
52W range
$245 – $321
Volume
2.7M
WallStSmart proprietary scores
65
out of 100
Grade: B
Buy
Investment rating
6.7
Growth
B5.0
Quality
C+8.0
Profitability
A4.3
Valuation
C2/9
Piotroski F-Score
Weak
0.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$302.00
+13.50%
12-Month target
$294.91
+10.84%
Intrinsic (DCF)
—
Margin of safety
—
3 Strong Buy3 Buy7 Hold1 Sell2 Strong Sell
Price chart
Stock snapshot
Strengths
+ Profit margin 63.30% — above average
+ Free cash flow $1.24B — positive
+ Revenue growth 14.40% QoQ
+ Debt/equity 0.13x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z 0.30 — distress zone
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $5.02B | $5.58B | $6.13B | $6.52B | $6.74B | $7.1B |
| Net income | $2.69B | $3.23B | $3.53B | $4.04B | $1.15B | — |
| EPS | — | — | — | — | $11.72 | $12.05 |
| Free cash flow | $2.97B | $3.38B | $3.60B | $4.19B | $1.24B | — |
| Profit margin | 53.61% | 57.83% | 57.52% | 62.02% | 63.30% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-18 | PIELL, HILDA HARRIS | Sale | 5,753 | $304.63 |
| 2026-05-15 | DUFFY, TERRENCE A | Sale | 25,996 | $298.14 |
| 2026-05-15 | DUFFY, TERRENCE A | Sale | 9,004 | $299.58 |
Peer comparison
Smart narrative
CME Group Inc trades at $266.08. representing a P/E of 21.38x trailing earnings. Our Smart Value Score of 65/100 indicates the stock is good. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 0.30, it sits in the distress. TTM revenue stands at $6.74B. with profit margins at 63.30%.
Frequently asked questions
What is CME Group Inc's stock price?
CME Group Inc (CME) trades at $266.08, on a P/E of 21.4x and a P/S of 13.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is CME Group Inc overvalued?
CME Group Inc carries a Smart Value Score of 65/100 (Grade B), which we rate Buy. That score blends growth, quality, and valuation into one read.
What is the price target of CME Group Inc (CME)?
The 12-month analyst consensus target is $302.00, about 13.5% above the current $266.08. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is CME Group Inc's revenue?
CME Group Inc's trailing twelve-month revenue is $6.74B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
CME Group Inc's Altman Z-Score is 0.30, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorFINANCIAL SERVICES
IndustryFINANCIAL DATA & STOCK EXCHANGES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio13.42x
ROE15.94%
Beta0.26
50D MA$290.76
200D MA$282.42
Shares out0.36B
Float0.36B
Short ratio—
Avg volume2.7M
Performance
1 week+0.00%
1 month-13.87%
3 months-17.85%
YTD-5.74%
1 year—
3 years—
5 years—